TERRY FALEYE: Open Payments
NPI 1629171764 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82,048 in 310 payments from 27 companies in 2025. Trend: 2023 $42,934 · 2024 $72,174 · 2025 $82,048
Speaker / faculty: $45,600Consulting: $19,017Travel & lodging: $8,695Food & beverage: $6,594Speaker / faculty: $1,850Education: $293
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 52 | $22,843 |
| ABBVIE INC. | 41 | $10,957 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 26 | $9,252 |
| GENZYME CORPORATION | 23 | $7,193 |
| Incyte Corporation | 14 | $6,753 |
| Janssen Biotech, Inc. | 29 | $5,340 |
| Arcutis Biotherapeutics, Inc. | 10 | $4,026 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $3,902 |
| Regeneron Healthcare Solutions, Inc. | 13 | $3,819 |
| Lilly USA, LLC | 6 | $2,743 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, Leqselvi, Zoryve, RINVOQ, ILUMYA, EBGLYSS.
Industry payments across TX — which companies pay providers there.
